NRX Pharmaceuticals
NRXP
NASDAQ
IPO2021
about NRXP
NRX Pharmaceuticals is a biopharmaceutical company focused on developing innovative treatments for rare and orphan diseases using precision medicine approaches.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $1.80 | $1.89 | $1.80 | $57.37M | 304.06K |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.27 | n/a | n/a | -1662.81% | -2433.88% | 0% |